Rolvedon 76961-0101

Generic: Eflapegrastim-Xnst

Product NDC

76961-0101

Manufacturer: Spectrum Pharmaceuticals, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: October 18, 2022
Application: BLA761148

Need to source Rolvedon? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eflapegrastim	13.2 mg/.6mL

Drug Class

Leukocyte Growth Factor [EPC]Granulocyte Colony-Stimulating Factor [CS]Increased Myeloid Cell Production [PE]

Packaging Options(1)

76961-0101-01

.6 mL in 1 SYRINGE, GLASS (76961-101-01)

View →